Indian Immunologicals
Manufacturer of human and veterinary biologicals and formulations with large-scale vaccine production, multiple manufacturing sites in India, WHO/GMP-certified and BSL-3 facilities, contract manufacturing services, and R&D collaborations for vaccine and biologics development. Maintains international product registrations and a nationwide distribution network.
Industries
Nr. of Employees
Very Large (1000+)
Products
Human vaccines (pediatric and rabies-focused portfolio)
Commercial production of vaccines used in national immunization programs, including rabies and pediatric vaccines (DPT, DT, TT, Hepatitis B and pentavalent combinations).
Veterinary vaccines and animal health products
Manufacture of veterinary vaccines (including FMD and rabies) and associated formulations, plus nutraceuticals and OTC animal health products.
Hormone therapeutics and fertility products
Production of injectable gonadotropins and other hormone products for fertility treatment including both purified urinary-derived and recombinant forms.
Formulations and probiotic products
Production of oral supplements and probiotic formulations, including enteric-coated probiotic tablets and soft-gel supplements.
Vaxtar-5
Sterile, turbid white uniform suspension of purified Diphtheria, Tetanus toxoid, Pertussis, Hepatitis B, and Hemophilus influenzae type-B (HiB).
Abhayrab
Lyophilized, purified, inactivated Rabies vaccine containing inactivated rabies virus (L. Pasteur 2061 Vero Strain propagated in Vero cells) with thiomersal as preservative.
Human vaccines (pediatric and rabies-focused portfolio)
Commercial production of vaccines used in national immunization programs, including rabies and pediatric vaccines (DPT, DT, TT, Hepatitis B and pentavalent combinations).
Veterinary vaccines and animal health products
Manufacture of veterinary vaccines (including FMD and rabies) and associated formulations, plus nutraceuticals and OTC animal health products.
Hormone therapeutics and fertility products
Production of injectable gonadotropins and other hormone products for fertility treatment including both purified urinary-derived and recombinant forms.
Formulations and probiotic products
Production of oral supplements and probiotic formulations, including enteric-coated probiotic tablets and soft-gel supplements.
Vaxtar-5
Sterile, turbid white uniform suspension of purified Diphtheria, Tetanus toxoid, Pertussis, Hepatitis B, and Hemophilus influenzae type-B (HiB).
Abhayrab
Lyophilized, purified, inactivated Rabies vaccine containing inactivated rabies virus (L. Pasteur 2061 Vero Strain propagated in Vero cells) with thiomersal as preservative.
Services
On-site manufacturing and development services for biologicals, oral solid dosage forms and small-volume parenterals provided to pharmaceutical and vaccine partners.
On-site manufacturing and development services for biologicals, oral solid dosage forms and small-volume parenterals provided to pharmaceutical and vaccine partners.
Expertise Areas
- Vaccine manufacturing (human and veterinary)
- Contract manufacturing of biologics and formulations
- Cell-culture and inactivated viral vaccine production
- Therapeutic protein and recombinant hormone production
Key Technologies
- Cell-culture vaccine production (e.g., Vero cell, human diploid cells)
- Inactivated viral vaccine manufacturing
- Recombinant protein production
- BSL-3 containment facilities
News & Updates
Announcement of rollout of a gE-deleted DIVA marker vaccine for infectious bovine rhinotracheitis (IBR).
Company pledges 5 lakh doses of veterinary anti-rabies vaccine for free-roaming dogs.
Announcement of work on a bi-valent human monoclonal antibody for rabies.
Exports of animal and human vaccines to more than 50 countries and over 300 global product registrations reported.
Reported first Indian launch of a tissue-culture based rabies vaccine.
Reported development of the world’s first vaccine for porcine cysticercosis.
Announcement of rollout of a gE-deleted DIVA marker vaccine for infectious bovine rhinotracheitis (IBR).
Company pledges 5 lakh doses of veterinary anti-rabies vaccine for free-roaming dogs.
Announcement of work on a bi-valent human monoclonal antibody for rabies.
Exports of animal and human vaccines to more than 50 countries and over 300 global product registrations reported.
Reported first Indian launch of a tissue-culture based rabies vaccine.
Reported development of the world’s first vaccine for porcine cysticercosis.